mortality/aging
• median survival is 90 days
|
cardiovascular system
• defects in matrix density in hearts
|
• myocytolysis
|
• mitochondrial swelling in hearts
|
• mice exhibit reduced mtDNA abundance, indicating mtDNA deletion in the heart
|
• cardiomyocyte hypertrophy, with multiple cytoplasmic granular figures consistent with mitochondria
|
• massive bilateral atrial enlargement
|
• mice exhibit septal thickening
|
• massive cardiomegaly with massive bilateral atrial enlargement
|
• increase in cavity dimensions of left and right ventricles
|
• mice exhibit ventricular free wall thickening
|
• echocardiography indicates increased left ventricular mass
|
• cardiomegaly with increased cavity dimensions of left ventricle and right ventricle, and free wall and septal thickening
|
cellular
• mitochondrial swelling in hearts
|
• mice exhibit reduced mtDNA abundance, indicating mtDNA deletion in the heart
|
• mitochondrial cristae dissolution in hearts
|
• 8-OHdG levels in mtDNA from mitochondria of hearts are elevated 3-fold, indicating mitochondrial oxidative stress
|
muscle
• myocytolysis
|
• mitochondrial swelling in hearts
|
• mice exhibit reduced mtDNA abundance, indicating mtDNA deletion in the heart
|
• cardiomyocyte hypertrophy, with multiple cytoplasmic granular figures consistent with mitochondria
|
• cardiomegaly with increased cavity dimensions of left ventricle and right ventricle, and free wall and septal thickening
|
growth/size/body
• massive cardiomegaly with massive bilateral atrial enlargement
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
cardiomyopathy | DOID:0050700 | J:122507 |